Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Creatine Kinase

Immunology & Autoimmune

CPKCreatine phosphokinaseTotal CK

Review status

Currently under review

Pending specialist review and validation.

What it shows

Creatine kinase (CK) is an enzyme found mostly in skeletal muscle, heart muscle, and the brain. The CK blood test measures the amount of this enzyme that has moved from your muscle cells into the bloodstream when those cells are stressed or injured.

Your clinician may order total CK on its own or alongside tests for specific CK isoenzymes and other markers to help identify where muscle injury is occurring.

Why it matters

CK helps evaluate muscle symptoms such as pain, weakness, cramps, or dark urine, and it is often checked after trauma, surgery, or seizures. It supports the assessment of conditions like muscle inflammation, inherited muscle disorders, medication related muscle injury, and severe muscle breakdown that can strain the kidneys.

CK can also rise with heart muscle injury, although cardiac troponin is now the preferred test for heart damage; CK may still provide useful context when interpreted with your history, exam, and timing of symptoms.

Understanding your results

Your CK result is interpreted in the context of your age, sex, health history, and recent activities. A modest increase can follow vigorous exercise or injections and often improves with rest; your clinician may suggest repeating the test after you avoid strenuous activity.

Persistent or marked elevation usually prompts a search for causes such as medications, thyroid disorders, infections, autoimmune muscle disease, or inherited conditions. Depending on symptoms, follow up may include urine testing, kidney and thyroid checks, autoimmune panels, repeat CK to look for trends, or heart specific tests if chest discomfort or shortness of breath is present.

Rarely, a low CK can occur with low muscle mass or certain medicines and is usually not worrisome by itself.

Reference ranges

31449 U/L
Female
0 days – 1 year
31449 U/L
Male
0 days – 1 year
34204 U/L
Female
1 year – 5 years
41277 U/L
Male
1 year – 5 years
44189 U/L
Female
5 years – 10 years
54269 U/L
Male
5 years – 10 years
28170 U/L
Female
10 years – 15 years
38255 U/L
Male
10 years – 15 years
53310 U/L
Female
15 years – 18 years
66505 U/L
Male
15 years – 18 years
24160 U/L
Female
18 years – 150 years
24195 U/L
Male
18 years – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Creatine Kinase

  • Recent strenuous activity

    Hard exercise, heavy lifting, or endurance events can temporarily raise CK. Avoid intense activity before your blood draw if your clinician wants a resting value.

  • Muscle procedures or injuries

    Intramuscular injections, electromyography, surgery, falls, or seizures can increase CK for a short period. Tell your clinician about any recent procedures or injuries.

  • Medications and supplements

    Statins, fibrates, antipsychotics, antivirals, daptomycin, colchicine, and some herbal products can elevate CK or worsen muscle symptoms. Do not stop medicines on your own; review them with your clinician.

  • Thyroid and kidney health

    Hypothyroidism, hyperthyroidism, and kidney problems can raise CK or change how your body clears it. Treating the underlying condition often improves CK levels.

  • Body composition and demographics

    Greater muscle mass is associated with higher baseline CK. Biological sex and ethnicity can also influence typical CK levels, which is considered when interpreting your result.

  • Pregnancy and postpartum

    CK patterns can differ during pregnancy and after delivery. Let your clinician know if you are pregnant or recently postpartum so results can be interpreted appropriately.

2026

References

  1. McGill University Health Centre. (2015, July 02). Creatine Kinase (Task CD 691250). Laboratory reference ranges.
  2. Gulati, M., Levy, P. D., Mukherjee, D., et al. (2021). 2021 AHA/ACC guideline for the evaluation and diagnosis of chest pain. Circulation, 144(22), e368–e454.
  3. Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014). An assessment by the Statin Muscle Safety Task Force: 2014 update. Journal of Clinical Lipidology, 8(3 Suppl), S58–S71.